Skip to content

Clinical trials

Phase 3 Heart Failure trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Netherlands Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20041
20063
20072
20081
20091
20101
20113
20132
20143
20151
20162
20176
20184
20191
20203
20221
20231
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting11
Terminated11
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
AstraZeneca6
Boehringer Ingelheim5
Amgen2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2
Novo Nordisk A/S2
University Medical Center Groningen2
Bayer1
BioControl Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure51
Cardiovascular Diseases5
Myocardial Infarction4
Renal Insufficiency, Chronic4
Stroke3
Aortic Valve Stenosis2
Cardiomyopathy, Dilated2
Coronary Artery Disease2
Death2
Diabetes Mellitus, Type 22

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.